Abstract
OC 44.3 Exploring Red Blood Cells as a Novel Tolerogenic Approach for Factor VIII Inhibitors Employing Immuno-Dominant FVIII Derived Peptides Presented on MHC Class Ii
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Research and Practice in Thrombosis and Haemostasis
Paper Title
Journal
Date
